Ayoxxa nets additional Series B funds
Ayoxxa Biosystems, a biotech firm in Germany and Singapore, has received an additional 2.3 million euros in its Series B funding. The investors in this round were BioMedPartners AG and Grazia Equity GmbH. Also, the company has named Andreas Richter as chief financial officer. His appointment becomes effective January 1, 2015.
2 December 2014•3 mins read
